{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:06:00Z","timestamp":1789067160061,"version":"build-2803163510"},"reference-count":15,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,7,31]]},"DOI":"10.2967\/jnumed.126.272990","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:10:15Z","timestamp":1789063815000},"page":"jnumed.126.272990","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Performance of [\n                    <sup>68<\/sup>\n                    Ga]Ga-DPI-4452 PET\/CT in Patients with Clear Cell Renal Cell Carcinoma: A Prospective Trial"],"prefix":"10.2967","author":[{"given":"Dongxing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangyou","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"2026091011100952000_jnumed.126.272990v1.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"2026091011100952000_jnumed.126.272990v1.2","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"2026091011100952000_jnumed.126.272990v1.3","unstructured":"NCCN clinical practice guidelines in oncology (NCCN Guidelines): kidney cancer. Version 2.2026. National Comprehensive Cancer Network website. www.nccn.org\/professionals\/physician_gls\/pdf\/kidney.pdf. Published April 14, 2026. Accessed May 2, 2026."},{"key":"2026091011100952000_jnumed.126.272990v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.03.006"},{"key":"2026091011100952000_jnumed.126.272990v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.04.081"},{"key":"2026091011100952000_jnumed.126.272990v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.072"},{"key":"2026091011100952000_jnumed.126.272990v1.7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41585-024-00962-z","article-title":"Molecular imaging of renal cell carcinomas: ready for prime time","volume":"22","author":"Wu","year":"2025","journal-title":"Nat Rev Urol."},{"key":"2026091011100952000_jnumed.126.272990v1.8","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000120241.50061.e4"},{"key":"2026091011100952000_jnumed.126.272990v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.03.015"},{"key":"2026091011100952000_jnumed.126.272990v1.10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S1470-2045(24)00402-9","article-title":"[89Zr]Zr-girentuximab for PET\u2013CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial","volume":"25","author":"Shuch","year":"2024","journal-title":"Lancet Oncol."},{"key":"2026091011100952000_jnumed.126.272990v1.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266309"},{"key":"2026091011100952000_jnumed.126.272990v1.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.267175"},{"key":"2026091011100952000_jnumed.126.272990v1.13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/cancers18020195","article-title":"Nuclear imaging in renal cell carcinoma: current evidence and clinical applications","volume":"18","author":"Al-Khanaty","year":"2026","journal-title":"Cancers (Basel)."},{"key":"2026091011100952000_jnumed.126.272990v1.14","unstructured":"Wang J Yan X Liu M . Preclinical and first-in-human study of carbonic anhydrase IX\u2013targeting theranostic pair, [68Ga]Ga\/[177Lu]Lu-NYM096, in clear cell renal cell carcinoma. J Nucl Med. April 16, 2026 [Epub ahead of print]."},{"key":"2026091011100952000_jnumed.126.272990v1.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268509"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:10:18Z","timestamp":1789063818000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":15,"alternative-id":["10.2967\/jnumed.126.272990"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272990","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}